| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 144,097 | 186,676 | 199,250 | 190,135 | | Cost of Revenue | 40,606 | 44,608 | 48,314 | 56,928 | | | Gross Profit |
-
| 142,068 | 150,936 | 133,207 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 83,892 | 86,958 | 75,510 | 65,285 | | Non Recurring | 227,558 |
-
|
-
| 223,405 | | Others | 169,878 | 98,400 | 72,836 | 251,844 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss |
-
| (43,290) | 2,590 | (407,327) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | (377,837) | (43,290) | 2,590 | (407,327) | | Interest Expense | 21,103 | 22,292 | 23,469 | 28,844 | | Income Before Tax | (398,940) | (65,582) | (20,879) | (436,171) | | Income Tax Expense | 60,467 | (36,049) | (436) | (81,088) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (459,407) | (29,533) | (20,443) | (355,083) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (459,407) | (29,533) | (20,443) | (355,083) | | Preferred Stock And Other Adjustments | (4,318) | (4,347) | (4,347) | (1,208) | | | Net Income Applicable To Common Shares | ($463,725) | ($33,880) | ($24,790) | ($356,291) |
|
0.01% Nasdaq 
Income Statement
